ARTICLE
8 November 2024

Deal Value Threshold Enforced In India

DA
DMD® Advocates

Contributor

DMD Advocates is a full service law firm in India. It blends its expertise and decades of experience in five core practice areas - litigation & dispute resolution, corporate, taxation, regulatory, and intellectual property rights. The Firm has a team of 75 lawyers with offices in New Delhi and Mumbai.
From 10 September 2024, deals valued over INR 20 billion (~USD 240 million) would require a pre-merger approval from the Competition Commission of India, if the target company meets the criteria for ‘substantial business operations in India'.
India Corporate/Commercial Law

From 10 September 2024, deals valued over INR 20 billion (~USD 240 million) would require a pre-merger approval from the Competition Commission of India (CCI), if the target company meets the criteria for 'substantial business operations in India' (SBOI). If the deal value threshold (DVT) and the SBOI criteria are met, the deal would trigger a CCI merger control filing even if the conventional turnover/ asset based thresholds are not met.

Earlier, many deals benefitted from the small target exemption as targets did not have the requisite turnover and assets in India. However, this small target exemption would not be available to deals triggering CCI filings based on DVT. Such deals will continue to benefit from other exemptions (such as, intra-group reorganisations and non-controlling minority investments).

A. How to calculate deal value?

Deal value would include every valuable consideration (including any indirect, deferred or non-cash consideration). If transaction documents do not record the true and complete deal value, it would be based on the value noted by the board. If the deal value cannot be established with reasonable certainty, it may be considered to be above the DVT.

Inclusions: Deal value would include consideration for:

  1. covenants or obligations agreed separately;
  2. inter-connected steps or transactions;
  3. other transactions between the target and the acquirer group in the last two years before the signing date;
  4. incidental arrangements (such as, tech licensing, marketing and raw material supplies) payable during two years post-closing;
  5. call options assuming full exercise of such options; and(vi)future outcomes specified in the transaction document.

Exclusions: Deal value excludes transaction costs such as fees paid to lawyers, investment bankers and statutory authorities.

B. How to assess if target meets the SBOI criteria?

  • For digital services: The target would be deemed to have SBOI if it has 10% or more of any of the following in India:
    1. total global number of users;
    2. total global gross merchandise value (GMV); or
    3. total global turnover.
  • For non-digital services: The target would be deemed to have SBOI if:
    1. its GMV in India is over 10% of its total global GMV and is over INR 5 billion (~USD 60 million); or
    2. its turnover in India is over 10% of its total global turnover and is over INR 5 billion (~USD 60 million).

C. What happens to deals which were signed, but not fully closed, before 10 September 2024?

If any such deal triggers a CCI filing based on the DVT, it needs to be notified to the CCI. Until the CCI approves, the deal must be put on a global standstill (as there is no provision to ring-fence India).

Originally published 11 Sep 2024

DMD Advocates is a leading full-service law firm with expertise in litigation, corporate, taxation, regulatory and intellectual property rights. The firm has a pan-India presence with principal offices in Delhi and Mumbai and associated offices in Bangalore, Chennai, Hyderabad, Cochin and Bhubanes-war.

DISCLAIMER: The views and opinions expressed in this article are those of the author and does not constitute a legal opinion/advice by DMD Advocates. The information provided through this article is not intended to create any attorney-client relationship between DMD Advocates and the reader and, is not meant for advertising the services of DMD Advocates or for soliciting work by DMD Advocates. DMD Advocates does not warrant the accuracy and completeness of this article and, the readers are requested to seek formal legal advice prior to acting upon any information provided in this article. Further, applicable laws and regulations are dynamic and subject to change, clarification and amendment by the relevant authorities, which may impact the contents of this article. This article is the exclusive copyright of DMD Advocates and may not be circulated, reproduced or otherwise used by the intended recipient without our prior permission.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More